Net profit of Ajanta Pharma rose 11.12% to Rs 225.26 crore in the quarter ended March 2025 as against Rs 202.72 crore during the previous quarter ended March 2024. Sales rose 11.04% to Rs 1170.41 crore in the quarter ended March 2025 as against Rs 1054.08 crore during the previous quarter ended March 2024.
For the full year,net profit rose 12.77% to Rs 920.39 crore in the year ended March 2025 as against Rs 816.17 crore during the previous year ended March 2024. Sales rose 10.44% to Rs 4648.10 crore in the year ended March 2025 as against Rs 4208.71 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 1170.41 | 1054.08 | 11 | 4648.10 | 4208.71 | 10 |
| OPM % | 25.39 | 26.40 | - | 27.10 | 27.85 | - |
| PBDT | 309.19 | 312.29 | -1 | 1333.27 | 1249.33 | 7 |
| PBT | 269.41 | 278.04 | -3 | 1189.16 | 1113.93 | 7 |
| NP | 225.26 | 202.72 | 11 | 920.39 | 816.17 | 13 |
Powered by Capital Market - Live News